Neuromodulation developer Halo Neuroscience closes its doors; Flow Neuroscience acquires assets

Flow acquires brain stim­u­la­tion tech­nol­o­gy devel­op­er Halo (Med­ical Device Network):

Flow Neu­ro­science has acquired the assets of brain stim­u­la­tion tech­nol­o­gy devel­op­er Halo Neu­ro­science to advance its research into depres­sion and oth­er men­tal health dis­or­der treatments.

The finan­cial details of the deal have not been disclosed.

Using Halo’s research in neu­ro­mod­u­la­tion field, Flow Neu­ro­science plans to enhance its cur­rent med­ical­ly cer­ti­fied tDCS head­set for depres­sion … A form of neu­ro­mod­u­la­tion, tDCS uses con­stant, low direct cur­rent deliv­ered via elec­trodes on the head.

In July 2019, Flow announced that it raised $1.5m towards its tran­scra­nial direct cur­rent stim­u­la­tion (tDCS) device for the treat­ment of depression.

News in Context:

About SharpBrains

SHARPBRAINS is an independent think-tank and consulting firm providing services at the frontier of applied neuroscience, health, leadership and innovation.
SHARPBRAINS es un think-tank y consultoría independiente proporcionando servicios para la neurociencia aplicada, salud, liderazgo e innovación.

Top Articles on Brain Health and Neuroplasticity

Top 10 Brain Teasers and Illusions


Subscribe to our e-newsletter

* indicates required

Got the book?